# Filing Detail

Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0001193125-25-005390
Filing Date
2025-01-13
Accepted
2025-01-13 17:27:51
Documents
6

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DFAN14A | d866658ddfan14a.htm | DFAN14A | 106269
2 | GRAPHIC | g866658866658_01.jpg | GRAPHIC | 9063
3 | GRAPHIC | g866658866658_02.jpg | GRAPHIC | 9150
4 | GRAPHIC | g866658g05a01.jpg | GRAPHIC | 177025
5 | GRAPHIC | g866658g07a01.jpg | GRAPHIC | 234431
6 | GRAPHIC | g866658g09a01.jpg | GRAPHIC | 207964
| Complete submission text file | 0001193125-25-005390.txt |  | 984087

Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filed by) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 1229
Type: DFAN14A
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 135 ROUTE 202/206 SUITE 6 BEDMINSTER NJ 07921
Business Address 135 ROUTE 202/206 SUITE 6 BEDMINSTER NJ 07921 (646) 440-9333
Intra-Cellular Therapies, Inc. (Subject) CIK: 0001567514 (see all company filings)

EIN.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 001-36274 | Film No.: 25527147
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)